Basic research

Effects of gingipain extracts on brain neuroinflammation in mice

  • Huanyu ZHANG ,
  • Yiting JIANG ,
  • Xiaochen ZHU ,
  • Zhiyan HE ,
  • Wei ZHOU ,
  • Zhongchen SONG
Expand
  • 1.Department of Periodontology, Shanghai Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine; College of Stomatology, Shanghai Jiao Tong University; National Center for Stomatology; National Clinical Research Center for Oral Diseases; Shanghai Key Laboratory of Stomatology, Shanghai 200011, China
    2.Laboratory of Oral Microbiota and Systemic Disease, Shanghai Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine; College of Stomatology, Shanghai Jiao Tong University; National Center for Stomatology; National Clinical Research Center for Oral Diseases; Shanghai Key Laboratory of Stomatology, Shanghai 200125, China
SONG Zhongchen, E-mail: szhongchen@sina.com.

Received date: 2022-01-28

  Accepted date: 2022-04-05

  Online published: 2022-05-28

Supported by

National Natural Science Foundation of China(82071112);Cross-disciplinary Research Fund of Shanghai Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine(JYJC202005)

Abstract

Objective

·To observe the effects of gingipain extracts on brain inflammation in mice.

Methods

·The gingipain extracts were obtained from Porphyromonas gingivalis ATCC33277 by sonication method combined with low temperature ultracentrifugation, followed by ultrafiltration and concentration. Gingipain extracts were identified by Western blotting after protein quantification. SDS polyacrylamide gel electrophoresis was performed and then transferred the proteins to the polyvinylidene fluoride (PVDF) membrane. After blockage, the proteins were probed with lysine-specific gingipain (Kgp) antibody and arginine-gingipain (Rgp) antibody, respectively, to detect the immunogenicity of gingipain in the extracts. The acute infection model was established by intraperitoneal gingipain extracts in C57BL/6N mice. The specific fluorescent substrates Z-His-Glu-Lys-MCA for Kgp and Boc-Phe-Ser-Arg-MCA for Rgp were used to detect the activities of two gingipains in plasma at different time points after intraperitoneal injection of gingipain extracts in mice. C57BL/6N mice were randomly divided into 4 groups, which were recorded as the control group, the gingipain group, the gingipain+Kgp inhibitor (COR388) group and the COR388 group, respectively. Mice in the gingipain+COR388 group were pre-treated with COR388 for 1 h, and then intraperitoneally injected with gingipain extracts. Twenty-four hours later, the samples were collected under anesthesia and the brains were processed sequentially by procedures such as fixing, dehydrating, embedding and dissecting. The microglia and astrocytes in the mouse cortex were labeled with ionized calcium binding adapter molecule 1 antibody (anti-Iba1) and glial fibrillary acidic protein antibody (anti-GFAP), respectively, and the activation of microglia and astrocytes in the cortex of the above four groups of mice were observed through immunohistochemistry. The expression of tumor necrosis factor-α (TNF-α) and interleukin-1β (IL-1β) were evaluated by enzyme linked immunosorbent assay (ELISA).

Results

·There were relatively clear bands around 50 000 and 70 000 in the Western blotting analysis of the gingipain extracts, suggesting that the extracts contained gingipain immunogenicity. Meanwhile, the gingipain extracts were biologically active, and the activity of gingipain in the plasma of mice showed a trend of first increasing and then decreasing after intraperitoneal injection of the gingipain extracts. The activity of plasma gingipain in mice reached a peak 4?8 h after intraperitoneal injection of gingipain extracts, and then gradually decreased. Immunohistochemistry results showed that the microglia and astrocytes in the cortex had increased volume of cell bodies and irregular protrusions, suggesting that intraperitoneal injection of gingipain extracts could activate microglia and astrocytes in the mouse brain. ELISA results showed that the expression of inflammatory factors (TNF-α and IL-1β) in cortex increased.

Conclusion

·Acute infection of gingipain extracts can induce neuroinflammation in mice.

Cite this article

Huanyu ZHANG , Yiting JIANG , Xiaochen ZHU , Zhiyan HE , Wei ZHOU , Zhongchen SONG . Effects of gingipain extracts on brain neuroinflammation in mice[J]. Journal of Shanghai Jiao Tong University (Medical Science), 2022 , 42(5) : 570 -577 . DOI: 10.3969/j.issn.1674-8115.2022.05.003

References

1 SANZ M, MARCO DEL CASTILLO A, JEPSEN S, et al. Periodontitis and cardiovascular diseases: consensus report[J]. J Clin Periodontol, 2020, 47(3): 268-288.
2 HELAL O, G?STEMEYER G, KROIS J, et al. Predictors for tooth loss in periodontitis patients: systematic review and meta-analysis[J]. J Clin Periodontol, 2019, 46(7): 699-712.
3 SLOTS J. Focal infection of periodontal origin[J]. Periodontol 2000, 2019, 79(1): 233-235.
4 WANG R P H, HO Y S, LEUNG W K, et al. Systemic inflammation linking chronic periodontitis to cognitive decline[J]. Brain Behav Immun, 2019, 81: 63-73.
5 JIA L, HAN N N, DU J, et al. Pathogenesis of important virulence factors of Porphyromonas gingivalis via toll-like receptors[J]. Front Cell Infect Microbiol, 2019, 9: 262.
6 ONO S, NAKAYAMA M, TACHIBANA M, et al. Construction and characterization of a PGN0297 mutant of Porphyromonas gingivalis: evidence of the contribution of PGN0297 to gingipain activity[J]. Acta Med Okayama, 2019, 73(4): 315-323.
7 SAKANAKA A, TAKEUCHI H, KUBONIWA M, et al. Dual lifestyle of Porphyromonas gingivalis in biofilm and gingival cells[J]. Microb Pathog, 2016, 94: 42-47.
8 HIROKI T, NAOKO S, SHUNSUKE Y, et al. Porphyromonas gingivalis induces penetration of lipopolysaccharide and peptidoglycan through the gingival epithelium via degradation of junctional adhesion molecule 1[J]. PLoS Pathog, 2019, 15(11): e1008124.
9 XU W Z, ZHOU W, WANG H Z, et al. Roles of Porphyromonas gingivalis and its virulence factors in periodontitis[J]. Adv Protein Chem Struct Biol, 2020, 120: 45-84.
10 WADHAWAN A, REYNOLDS M A, MAKKAR H, et al. Periodontal pathogens and neuropsychiatric health[J]. Curr Top Med Chem, 2020, 20(15): 1353-1397.
11 DIETERLE M P, HUSARI A, STEINBERG T, et al. Role of mechanotransduction in periodontal homeostasis and disease[J]. J Dent Res, 2021, 100(11): 1210-1219.
12 OLSEN I. Porphyromonas gingivalis-induced neuroinflammation in Alzheimer's disease[J]. Front Neurosci, 2021, 15: 691016.
13 LIU Y C, WU Z, NAKANISHI Y, et al. Infection of microglia with Porphyromonas gingivalis promotes cell migration and an inflammatory response through the gingipain-mediated activation of protease-activated receptor-2 in mice[J]. Sci Rep, 2017, 7(1): 11759.
14 NONAKA S, NAKANISHI H. Secreted gingipains from Porphyromonas gingivalis induce microglia migration through endosomal signaling by protease-activated receptor 2[J]. Neurochem Int, 2020, 140: 104840.
15 PATHIRANA R D, O'BRIEN-SIMPSON N M, VEITH P D, et al. Characterization of proteinase-adhesin complexes of Porphyromonas gingivalis[J]. Microbiol Read Engl, 2006, 152(Pt 8): 2381-2394.
16 DOMINY S S, LYNCH C, ERMINI F, et al. Porphyromonas gingivalis in Alzheimer's disease brains: evidence for disease causation and treatment with small-molecule inhibitors[J]. Sci Adv, 2019, 5(1): eaau3333.
17 TIWARI S, ATLURI V, KAUSHIK A, et al. Alzheimer's disease: pathogenesis, diagnostics, and therapeutics[J]. Int J Nanomed, 2019, 14: 5541-5554.
18 CALSOLARO V, EDISON P. Neuroinflammation in Alzheimer's disease: current evidence and future directions[J]. Alzheimer's Dement, 2016, 12(6): 719-732.
19 KUMAR D K V, CHOI S H, WASHICOSKY K J, et al. Amyloid-β peptide protects against microbial infection in mouse and worm models of Alzheimer's disease[J]. Sci Transl Med, 2016, 8(340): 340ra72.
20 MALDONADO A, LAUGISCH O, BüRGIN W, et al. Clinical periodontal variables in patients with and without dementia: a systematic review and meta-analysis[J]. Clin Oral Investig, 2018, 22(7): 2463-2474.
21 CHEN C K, WU Y T, CHANG Y C. Association between chronic periodontitis and the risk of Alzheimer's disease: a retrospective, population-based, matched-cohort study[J]. Alzheimer's Res Ther, 2017, 9(1): 56.
22 CHOI S, KIM K, CHANG J, et al. Association of chronic periodontitis on Alzheimer's disease or vascular dementia[J]. J Am Geriatr Soc, 2019, 67(6): 1234-1239.
23 DIOGUARDI M, CRINCOLI V, LAINO L, et al. The role of periodontitis and periodontal bacteria in the onset and progression of Alzheimer's disease: a systematic review[J]. J Clin Med, 2020, 9(2): 495.
24 SCHENKEIN H A, PAPAPANOU P N, GENCO R, et al. Mechanisms underlying the association between periodontitis and atherosclerotic disease[J]. Periodontol 2000, 2020, 83(1): 90-106.
25 CHHIBBER-GOEL J, SINGHAL V, BHOWMIK D, et al. Linkages between oral commensal bacteria and atherosclerotic plaques in coronary artery disease patients[J]. NPJ Biofilms Microbiomes, 2016, 2: 7.
26 ANGELICA V, ELISA P, MARCELLO R, et al. The potential role of gut microbiota in Alzheimer's disease: from diagnosis to treatment[J]. Nutrients, 2022, 14(3): 668.
27 HADITSCH U, ROTH T, RODRIGUEZ L, et al. Alzheimer's disease-like neurodegeneration in Porphyromonas gingivalis infected neurons with persistent expression of active gingipains[J]. J Alzheimer's Dis, 2020, 75(4): 1361-1376.
28 HANSEN D V, HANSON J E, SHENG M. Microglia in Alzheimer's disease[J]. J Cell Biol, 2018, 217(2): 459-472.
29 CARTER S F, HERHOLZ K, ROSA-NETO P, et al. Astrocyte biomarkers in Alzheimer's disease[J]. Trends Mol Med, 2019, 25(2): 77-95.
30 NICHOLS M R, ST-PIERRE M K, WENDELN A C, et al. Inflammatory mechanisms in neurodegeneration[J]. J Neurochem, 2019, 149(5): 562-581.
31 KAUR D, SHARMA V, DESHMUKH R. Activation of microglia and astrocytes: a roadway to neuroinflammation and Alzheimer's disease[J]. Inflammopharmacology, 2019, 27(4): 663-677.
32 LEYNS C E G, HOLTZMAN D M. Glial contributions to neurodegeneration in tauopathies[J]. Mol Neurodegener, 2017, 12(1): 50.
33 WU Y W, DISSING-OLESEN L, MACVICAR B A, et al. Microglia: dynamic mediators of synapse development and plasticity[J]. Trends Immunol, 2015, 36(10): 605-613.
34 PHATNANI H, MANIATIS T. Astrocytes in neurodegenerative disease[J]. Cold Spring Harb Perspect Biol, 2015, 7(6): 1-18.
35 DECOURT B, LAHIRI D K, SABBAGH M N. Targeting tumor necrosis factor alpha for Alzheimer's disease[J]. Curr Alzheimer Res, 2017, 14(4): 412-425.
36 MENDIOLA A S, CARDONA A E. The IL-1β phenomena in neuroinflammatory diseases[J]. J Neural Transm, 2018, 125(5): 781-795.
Outlines

/